Development of multi-epitope subunit vaccine for protection against the norovirus' infections based on computational vaccinology. Issue 7 (3rd May 2022)

• Record Type: Journal Article
• Authors: Ahmad, Irfan; Ali, Syed Shujait; Zafar, Bisma; Hashmi, Huma Farooque; Shah, Ismail; Khan, Shahzeb; Suleman, Muhammad; Khan, Mazhar; Ullah, Saif; Ali, Shahid; Khan, Jafar; Ali, Mohammad; Khan, Abbas; Wei, Dong-Qing
• Is Part Of: Journal of biomolecular structure & dynamics. Volume 40:Issue 7(2022)
• Page Start: 3098
• Page End: 3109
• Publication Date: 2022-05-03
• Subjects: Norovirus -- epitopes -- docking -- MD simulation -- in-silico cloning; Biomolecules -- Periodicals; Molecular structure -- Periodicals; Molecular Biology -- Periodicals; Biomechanics -- Periodicals; 572
• DOI: 10.1080/07391102.2020.1845799
• Languages: English
• ISSNs: 0739-1102

Abstract

Abstract: Human Norovirus belongs to a family Calciviridae, and was identified in the outbreak of gastroenteritis in Norwalk, due to its seasonal prevalence known as "winter vomiting disease." Treatment of Norovirus infection is still mysterious because there is no effective antiviral drugs or vaccine developed to protect against the infection, to eradicate the infection an effective vaccine should be developed. In this study, capsid protein (A7YK10), small protein (A7YK11), and polyprotein (A7YK09) were utilized. These proteins were subjected to B and T cell epitopes prediction by using reliable immunoinformatics tools. The antigenic and non-allergenic epitopes were selected for the subunit vaccine, which can activate cellular and humoral immune responses. Linkers joined these epitopes together. The vaccine structure was modelled and validated by using Errat, ProSA, and rampage servers. The modelled vaccine was docked with TLR-7. The stability of the docked complex was evaluated by MD simulation. To apply the concept in a wet lab, the reverse translated vaccine sequence was cloned in pET28a (+). The vaccine developed in this study requires experimental validation to ensure its effectiveness against the disease. Communicated by Ramaswamy H. Sarma